Analysis between ABO blood group and clinical outcomes in COVID-19 patients and the potential mediating role of ACE2.

Zeng, Xianfei; Fan, Hongyan; Kou, Jinxin; Lu, Dongxue; Huang, Fang; Meng, Xi; Liu, Haiying; Li, Zhuo; Tang, Mei; Zhang, Jing; Liu, Nannan; Hu, Xingbin

Zeng, Xianfei; Fan, Hongyan; Kou, Jinxin; Lu, Dongxue; Huang, Fang; Meng, Xi; Liu, Haiying; Li, Zhuo; Tang, Mei; Zhang, Jing; Liu, Nannan; Hu, Xingbin.

Afiliación

Zeng X; School of Medicine, Northwest University, Xi'an, China.
Fan H; Xi'an Area Medical Laboratory Center, Xi'an, China.
Kou J; Department of Blood Transfusion, 940 Hospital, Lanzhou, China.
Lu D; School of Medicine, Northwest University, Xi'an, China.
Huang F; Department of Anesthesiology and Perioperative Medicine, Xijing Hospital, Xi'an, China.
Meng X; Department of Laboratory Medicine, Xi'an Chest Hospital, Xi'an, China.
Liu H; Xi'an Area Medical Laboratory Center, Xi'an, China.
Li Z; Xi'an Area Medical Laboratory Center, Xi'an, China.
Tang M; Department of Laboratory Medicine, First Affiliated Hospital of Xi'an Medical University, Xi'an, China.
Zhang J; Department of Blood Transfusion, Tangdu Hospital, Xi'an, China.
Liu N; Department of Blood Transfusion, Xijing Hospital, Xi'an, China.
Hu X; Intensive Care Center, Xijing Hospital, Xi'an, China.

Front Med (Lausanne) ; 10: 1167452, 2023.

Article en En | MEDLINE | ID: mdl-37425304

Palabras clave

ABO blood type; ACE2; AKI; ARDS; COVID-19; susceptibility

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Front Med (Lausanne) Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google